fourth annual ent for the pa-c | april 24-27, 2014 ... - chronic rhinoinusitis - ferguson.pdffistula...
TRANSCRIPT
3/18/2014
1
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Chronic Rhinosinusitis Subcategories and unusual manifestations of
systemic disorders.BJ Ferguson MD
Director Division of Sino‐nasal Disorders and Allergy
University of Pittsburgh
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Disclosure
• Teva: Advisory Board
• Meda: Advisory Board
• Integrity: CME speaker
• Sanofi Aventis: Research – Industry sponsored Phase III trial
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Learning Objectives
• Describe Chronic Rhinosinusitis and its subcategories, discussing diagnosis and management.
• Identify the role and evaluation of eosinophilicdisease in Chronic Rhinosinusitis.
• Recognize the unusual manifestations of systemic disease in the nose such as Wegener’s and narcotic abuse.
3/18/2014
2
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Categorizing CRS
No Nasal polys
• Odontogenic
• Pyogenic
• Anatomic
With Nasal Polyps
• With Eosinophilia
– AFS
– AERD
– Food Hypersensitivity
• Without Eosinophilia– Cystic Fibrosis
– Antral Choanal Polyp
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Boring through the alveolus after excavation of a tooth (Cowper method)
• After extraction of the offending tooth, (usually second premolar or first molar)
• Pledglet of cotton saturated with a 20% solution of cocaine packed into the cavity for 10 minutes
• A large dental drill or a guarded Hartmann borer is now used to make an opening into the sinus.
Skillern , 3rd ed 1920
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Must be recognized in order to be treated effectively
• I recommended extraction Rt. Rear molar
• Repeat Dental consult: “no dental pathology”
• Patient and I insist on dental extraction
• Tooth extracted
• No recurrence x 1 year
3/18/2014
3
July 2010: telephone consult
advice on patient with sinus CT showing right max, frontal sinusitis.
She is on MTX for RA and has been sx x 7 months, failed course of augmentin
Microbiology of intracranial abscesses associated with sinusitis of odontogenic origin.Brook I.Ann Otol Rhinol Laryngol. 2006 Dec;115(12):917‐20
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
2013 Management of OMS
Resolve dental infection Root canal or extractionCan try office irrigation and antibiotics
Culture frequently negative
If no subsequent resolution, ESS with irrigation
If anticipate Oral‐Antralfistula with extraction then concomitant ESS and repair
Between 1995 and 2010: 11 of 85 (13%) sinus guidelines specifically mentioned odontogenic
maxillary sinusitis (OMS)
Longhini A, Ferguson BJ: Clinical Aspects of OMS: a case series, IFAR 2011
3/18/2014
4
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Anatomic causes
• OMC obstruction
• Unusual from orbital decompression for Graves
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Maxillary sinus tap
• Same patient, 3 days preop, decompressed with inferior meatal tap
• Video of antral tap
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Mimics and Comorbidities of CRS
• Migraine
• CFS/fibromyalgia
• Allergic rhinitis
• OSA
• GERD
3/18/2014
5
CRS + (n=75) and CRS neg (n=50)
CRS + CT sx > CRS nl CT
CRS nl CT sx> CRS + CT
.01
Ferguson et al: CID 2012Prospective observational study of CRS
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Ferguson et al: CID 2012Prospective observational study of CRS
• 30% of CT+CRS had endoscopic purulence
• 0% of CT‐ CRS had endoscopic purulence
• Both groups reported similar antibiotic use and response to therapy – 50%
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
PPI therapy Improves symptoms of “PND” Vaezi M; gastroenterology 2010
• BRPCT
• Nl sinus CT
• Negative allergy testing
• PPI x 16 weeks vs placebo
• Significant improvement in PND sx at 8 weeks and 16 weeks
• No GI/reflux test predictive of response
3/18/2014
6
OSA, recumbent nasal blockage, GERDand the ANS a unifying hypothesis
Normal Sleep
GERD VMR (nasalcongestion)
OSA
Parasympathetic same ↑ same Same or ↓
Sympathetic ↓ same ↓ ↓↓
Para/sympathetic > 1 >1 >1 >1
Jaradeh, Smith et al Laryngoscope 2000
Theory: ANS impacts multiple disorders which may in turn influence
comorbidities
Parasympathetic > Sympathetic
ANS dysfunction
Treatment
• VMR and Recumbinantcongestion
– oxymetazolin with NSS
– Turbinate reduction
– Ipratrobium nasal spray
• OSA– positive pressure, IX nerve
stimulation
• GERD– Proximal Vagotomy
Baseball in style at Miller Park
3/18/2014
7
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Allergies and Sinusitis: the Rational Patient Experimenta practical method for best treatment of nasal symptoms
regardless of cause.
Sitska, Alaska 8/2012
20
Learning Objectives• Formulate a logical management plan for patients with allergic rhinitis (AR) or Chronic Rhinosinusitis (CRS) according to available evidence‐based clinical guidelines MAKE ALLERGY /NASAL CARE EASY
• Recognize the symptoms of AR and CRS and understand impact upper airway can have have on the lower airway “unified airway” Asthma and CRS / AR coexist
• Describe the characteristics of available therapeutic options for patients with AR and CRS
• Implement strategies to improve treatment adherence while considering patient preferences for therapy
Diagnosing by SymptomsAllergic rhinitis Non allergic rhinitis CRS
congestion + + +
Drainage PND + + +Facial pain and pressure
+ + +
rhinorrhea + + +cough + + +sneezing + +Nasal itch + +/‐Upper teeth pain 40% dental
infections
Rotten odor 50% of dental sinusitis
Decreased smell +/‐ +/‐ Majority of nasal polyp
3/18/2014
8
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Medications approved by Indication
• Allergic rhinitis (SAR, PAR): antihistamines (oral and topical), antihistamines/decongestants, nasal steroid sprays, leukotriene modulators (montelukast)
• Nonallergic Rhinitis: none for > 10 years, FDA changed criteria for indication. Some steroid sprays and azelastine
• Chronic Rhinosinusitis: nasal steroid sprays for nasal polyps
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
How often is CRS substantiated by an abnormal sinus CT scan?
• Up to 30% of asymptomatic patients have some abnormality of sinuses on CT
• 40% of patients with strong litany of CRS symptoms x 3 months have normal sinus CT
• Sinus CT is a “picture in time” and is abnormal in 80% of patients with a cold, however in 2 weeks these changes are much improved
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Allergic Rhinitis: Targeted Symptom Relief
Nasal congestion
Sneezing Nasal itching
Eye Sx
Rhin-
norrhea
Nasal Steroid +++ +++ +++ + +++Antihistamines 1st
2nd
+/-
+/- *
++
++
++
++
++
++
++
-
Decongestants +++ - - - -
Ipratropium - - - - +++Mast Cell Stablizer
+ + + +/- +
LTR ++ + + + +* Azelastine has +++ decongestive properties
3/18/2014
9
What is the Rational Patient Experiment?
• In an experiment, one variable is changed to observe whether it changes the out come of the experiment
• The outcome is: “How do your nose/sinus symptoms feel; how do you feel?”
• The Variable is the Medication or Intervention
• Each pharmacologic intervention is tried one at a time
Snow fall in Pride’s Crossing, MA Jan 2009
Rational Patient Experiment
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
RPE: Instructions•
Our goal is to relieve your nose and sinus problems with the fewest number of medications. People respond differently to medicines and we will not know which medicine works best for you, or even causes a side effect, without doing an experiment.
The RATIONAL PATIENT EXPERIMENT: Try each checked medicine ONE AT A TIME.
If the medicine does NOT make you feel better in 3 to 4 days then STOP the medicine and try the next medicine listed.
If the medicine makes you feel PARTIALLY better, but not completely symptom free, then ADD the next medicine listed to the medicine that was partially helping you.
If the medicine RELIEVES your symptoms, then CONTINUE it for at least several days or weeks. If you are feeling back to normal, then stop the medicine, but restart it if your symptoms start to return.
3/18/2014
10
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
EMRS (n=69) vs. AFS (n=431)
0102030405060708090
100
AGE Male (%) Polyps (%) UnilateralDz(%)
EMRSAFS
*P<.001 # P<.00001
* #
Eosinophilic CRS multiple often overlapping causes
.
Spector SL. J Allergy Clin Immunol. 1997;99:S773‐S780.
AERD
Eosinophilic CRS
Nasal Polyposis?
+ food allergies
Super antigen IGE mediated
FungusAFS
ChurgStrauss
Asthma
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Categorization of Eosinophilic CRS
1. Fungus “allergic fungal sinusitis”a. TLR4 Independent(classic)
TLR4 Dependent triggered by coagulation byproducts induced by fungal or other proteases Science 2013; NEJM 11/2013
2. Bacteria – “Superantigen”3. Food Hypersensitivity4. Aspirin Exacerbated
Respiratory Disease5. Eosinophilic Vasculitis
(Churg‐Strauss Syndrome)
b.
3/18/2014
11
Spectrum of Fungal SinusitisImmunologic Spectrum
compromised competent ? Allergic
Invasive-acuteMucor
Aspergillus
Fusarium
Pseudallescherii
Chronic
invasiveFungus
Balls
Aspergillus
NA EFRS AFSBipolaris
Aspergillus
Curvularia
Alternaria
Saprophytic fungus
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
N.P. A 42 year old woman with a 6 month history of worsening headaches and scant discolored drainage is admitted through the ER
• multiple courses of antibiotics over last 6 months ‐ no improvement
• IDDM – in moderate control
• Renal transplant 2 years earlier
• ESS to remove fungus ball 10 years earlier
• PE: in moderate distress because of pain
• Temp: 37.9 C
• Without cranial neuropathy
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Sinus CT on Admision
3/18/2014
12
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
What do you do next?
A. IV Clindamycin, Rifampin and Gentamicin
B. MRI
C. urgent ESS with debridement
D. Amphotericin B
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Mimics of AFS ‐ EMRS
AFS: fungi present in eosinophilic mucin with IgE mediated allergy to cultured fungus
No fungal allergy, no fungus on path just eosinophilic mucin
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Allergic Fungal Sinusitis versus Eosinophilic Mucin Rhinosinusitis
without Fungus (AFS – Like)Ferguson, BJ; Laryngoscope 2000
431 AFS total cases
418 literature
13 personal series
69 EMRS total cases
40 from literature
29 personal series
Toulouse ARS 2012
3/18/2014
13
Therapeutic Implications – AFS vsAFS‐like or EMRS
AFS EMRS
Surgery + +
Steroids + +
Nasal lavage + +
Antifungals + -
Immunotherapy + -
Omaluzumab ? Superantigen
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
1999‐2006 Ponikau and the Anti fungal controversies
• 98% of CRS patients with fungus• 70% improved with amphotericin irrigations, non
randomized trial• Wechta DBRCT: no difference between saline lavage and
amphotericin, excluded AFS, but 3 patients had 50% improvement on CT in Amp arm and none on Placebo
• Ebbens DBRCT: definitive study, NO difference amphotericin irrigations or placebo
• But study has not been done in just AFS patients, especially post op
Antifungal washes cure most CRS, because fungus is everywhere and so are eosinophils; 1999 Ponikau
Balloons cure sinus disease because theyatraumatically enlarge the sinus ostia
3/18/2014
14
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
“The obstacle to discovery is not ignorance,it is the illusion of knowledge” Dan Boorstin
• Best Evidenced Based Review is EPOS 2012
• For CRS only saline irrigations and topical steroids show efficacy.
• No evidence for antibiotics, antifungals
• Future: targeted agents like duplizumab (anti IL4 receptor)
Hana no hana “nose flowers”Colorized TEM of nasal epithelium and cilia
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Can Elimination Challenge Food Diets Help?
• Prospective collection of data on CRS patients undergoing ECFD
• 43 Adults with CRS: 21 without nasal polyps, 22 without
• Intervention: Completion of QoLsurveys, nasal endoscopy, allergy testing, ECFD
• 49% reported improvement in sinonasal symptoms
• 22% reported increased energy, decreased abdominal symptoms
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Elimination Challenge Food Diet
• Take food out of diet x 5 to 10 days, then ingest and monitor for symptoms for next 24 hours.
3/18/2014
15
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Can Elimination Challenge Diets Help?
• Most commonly reported food was wheat (43%) followed by dairy (28%), or both 14%
• Endoscopic improvement in 24%
• 33% of responders had positive allergy testing
• Only 9% aware of food allergies prior to office visit
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
UNUSUAL CAUSES OF CHRONIC RHINOSINUSITIS (CRS)
• VASCULITIC– CHURG STRAUSS
(EOSINOPHILIC VASCULITIS)
– LUPUS– Granulomatosis with
polyangiitis (GPA) formerly known as WEGENER’S GRANULOMATOSIS
• GRANULOMATOUS– SARCOID– RHINOSCLEROMA
• Other – Intranasal abuse with
oxycontin or acetomenophin
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Vasculitic Causes of CRS• Granulomatosis with polyangiitis (GPA) used to be known as Wegener;sGranulomatosis
• Renal, Pulmonary and Upper Airway
• Nasal bleeding and septal perforation
• Elevated cANCA, WSR,
• Path: granulomas and vasculitis
3/18/2014
16
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Sarcoid
• Early: submucosalmasses along septum
• Later: sticky mucus crusting with bacterial colonization
• Occasionally perforation
• Dx: usually bx with noncaseatinggranulomas
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Eosinophilic VasculitisChurg strauss syndrome
1. Allergic stage: 90% have asthma 3 to 5 years prior to dx
2. Eosinophilic stage: hypereosinophilia;
3. Vasculitic Stage: GI , cardiac (1/2 of deaths)
• Diagnosis 4/6 criteria
– pANCA
– Asthma
– >10% Eosinophilia
– Neuropathy
– Pulmonary infiltrates
– CRS
– Extravascular E’s
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Conclusion and a few additional pearls
• CRS symptoms x 12 weeks, sx are nonspecific– Decreased smell– Drainage– Congestion– Facial pressure
• Initially Rational Patient Experiment– Saline nasal washes– Nasal Steroid Spray– If purulent – culture,
nasopharyngeal swab surrogate for sinus
• CT scan if impending complication– Cone Beam CT less radiation
• Only get CT if it will change therapy or if ESS planned
• Usually after endoscopic evaluation and management and persistence
3/18/2014
17
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Summary
• Only Level 1 evidence for topical steroids and saline washes
• No good evidence for antibiotics (culture directed studies not done)
• Dental cause (maxillary), rotten smell, sometimes tooth pain
• May require CT for diagnosis
Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA
Thank you